Diabetes and Metabolic Syndrome Program Publications and Abstracts

 

PUBLICATIONS

  • Smith A, Fogelfeld L, Bakris G. New Therapies in Diabetes- Thiazolidinediones. Emerging Drugs 2000; 5 (4) 1-16.
  • Collins B, Chiappetta G, Schneider A, Santoro M, Pentimalli F, Fogelfeld L, Gierlowski T, Shore-Freedman E, Jaffe G, AND Fusco A. RET expression in papillary thyroid cancer from patients irradiated in childhood for benign conditions. Journal of Clinical Endocrinology and Metabolism 2002; 87(8) 3941- 3946
  • Schneider AB and Fogelfeld L Pathogenesis of thyroid cancer(pp:569-575). Oxford Textbook of Endocrinology (John A.H. Wass and Stephen A. Shalet, Editors) Oxford University Press, 2002.
    26.
  • Ambika Babu, C.R.Kannan, Theodore Mazzone. Diabetes, Hyperlipidemia and Stroke” Pages 173-182. In Stroke Prevention Published by Kluwer and Plenum, Parthenon publishing, 2002.
  • R Kazlauskaite and L Fogelfeld. Insulin Therapy in Type 2 Diabetes. Disease a Month 2003 49 (6) 373¬420
  • Akhrass F, Evans AT, Wang Y, Rich S, Kannan CR, Fogelfeld L, Mazzone T.Hormone Replacement Therapy is Associated with less Coronary Atherosclerosis in Postmenopausal Women. J Clin Endocrinol Metab. 2003 Dec;88(12):5611-4.
  • Ambika Babu, MD and Arcot Dwarkanathan MD, FACE. Cushing’s Syndrome from Ectopic ACTH Production by a Metastatic Gastrinoma. Endocrine Practice, 2003 May-June 9(3):229-32.
  • Evans, A, Kazlauaskaite, R Training in flexible intensive insulin management improved glycemic control and quality of life in type I diabetes, ACP J. Club 2003 May-June 138(3):68
  • Steinle NI, Kazlauskaite R, Imumorin IG, Hsueh WC, Pollin TI, O’Connell JR, Mitchell BD, Shuldiner AR.Variation in the lamin A/C gene: associations with metabolic syndrome. Arterioscler Thromb Vasc Biol. 2004 Sep;24(9):1708-13. Epub 2004 Jun 17.
  • Fu M, Kazlauskaite R, Baracho Mde F, Santos MG, Brandao-Neto J, Villares S, Celi FS, Wajchenberg BL, Shuldiner AR. Mutations in Gng3lg and AGPAT2 in Berardinelli-Seip congenital lipodystrophy and Brunzell syndrome: phenotype variability suggests important modifier effects. J Clin Endocrinol Metab. 2004 Jun;89(6):2916-22.
  • John R and Fogelfeld L. Inpatient Management of Diabetes and Hyperglycemia. Disease a Month 200450
    (8) 433-480
  • Babu A, Herdegen J, Fogelfeld L, Shott S And Mazzone T . Treatment of Obstructive Sleep Apnea with Continuous Positive Airway Pressure Improves Glycemic Control in Type 2 Diabetes. Archives of Internal Medicine (Accepted).
  • Schiff G, Kim S, Krosnjar N, Wisniewski M, Bult J, Fogelfeld L and McNutt R. Missed Hypothyroidism Uncovered by Linking Laboratory and Pharmacy Data. Archives of Internal Medicine (Accepted).
  • A.Babu, E. Lacuesta, S. Patel. Blastomycosis masquereding as thyroid mass. . Endocrine Practice (Accepted)
  • Kazlauskaite R, Evans A, Mazzone A, Fogelfeld L. Ethnic Differences Predicting Ketonuria In Type 2 Diabetes Journal Of Diabetes And Its Complications (submitted).
  • Ambika Babu, C.R.Kannan And Theodore Mazzone. Hyperlipidemia And Peripheral Vascular Disease, In Lower Extremity Arterial Disease. D.G. Caralis And G.L. Bakris Editors. (In Press).

ABSTRACTS

  • Ambika Babu, Billie S. Strauss, Kelly Kozik, Carolyn Pesquira and Leon Fogelfeld. Abs No 1622-P. Psychosocial Characteristics and Glycemic Control in Patients with Diabetes in an Urban Setting American Diabetes Association, June 2001 at Philadelphia.
  • Babu, J. Herdegen, C. Kannan, L Fogelfeld, S. Shott, T. Mazzone. Treatment Of Obstructive Sleep Apnea With Continuous Positive Airway Pressure Improves 24 Hours Glucose Control. American Diabetes Association, 62nd Annual Meeting, 2002, San Francisco.
  • L. Fogelfeld, K Kozik. Challenges And Barriers To Diabetes Care In A Huge Underserved Urban Population. American Diabetes Association, 62nd Annual Meeting, 2002, San Francisco.
  • Fu M, Kazlauskaite R, Wajchenberg BL, Celi FS, Shuldiner AR. Mutations in BSCL 1 Locus and BSCL 2 (seipin) Are Not Common Causes of Congenital Generalized Lipodystrophy Syndromes (2246 PO). 2002 ADA 62nd Scientific Sessions Abstracts. Diabetes 51(S): A544.
  • Ambika R. Babu, Evelyn Lacuesta, Subhash Patel. Severe hypoglycemia-an unusual presentation of adrenocortical carcinoma”. Abstract number – 51. Presented at the 11th Annual Meeting and Clinical Congress of the American Association of Clinical Endocrinologists held on May 2002, Chicago, Illinois.
  • C. Yerrapareddy, E. Lacuesta, S. Patel. Blastomycosis masquereding as thyroid mass. . Presented at the 11th Annual Meeting and Clinical Congress of the American Association of Clinical Endocrinologists held on May 2002, Chicago, Illinois.
  • S. Shah, S. Kim, M. Wisniewsky, R. Tomar, G. Schiff and L. Fogelfeld. Use of public hospital electronic registries to assess the burden of diabetes in a large underserved population. American Diabetes Association, 63nd Annual Meeting, 2003, New Orleans.
  • G Staskus, L Fogelfeld. High dose I -131 therapy in Graves’ disease. The 85th Annual Meeting of The Endocrine Society, Philadelphia, June 2003.
  • Fu M, Kazlauskaite R, Barracho FP, Goretti N Santos M, Villares S, Celi, FS, Wajchenberg BL and Sculdiner AR. Mutations in Gng31g and AGPAT2 in Baradinelli-Seip Congenital Lipodystrophy and Brunzell Syndrome: Phenotype Variability Suggests Important Modifier Effects (1076 P). 2003 ADA 62nd Scientific Sessions Abstracts, Diabetes 52(S2): A250.
  • Fu M, Kazlauskaite R, Barracho FP, Goretti N Santos M. Villares S, Celi, FS, Wajchenberg BL and Sculdiner AR. Congenital Generalized Lipotrophic Diabetes in Large Kindred from Brazil is Caused by a Mutation in the BSCL2 Gene (1055 P). 2002 ADA 62nd Scientific Sessions Abstracts. Diabetes 51(S2): A260.
  • Meenakshi Pande, Maria D Camargo, Carolyn Lopez, and Leon Fogelfeld. Metabolic Syndrome Factors in Hispanic Adolescents: Association with Atherosclerosis Markers. American Diabetes Association, 64th Annual Meeting, 2004, Orlando. Maria D Camargo, Meenakshi Pande, Carolyn Lopez, and Leon Fogelfeld. Social and Behavioral Factors are associated with Metabolic Syndrome Components in Hispanic Adolescents. American Diabetes Association, 64th Annual Meeting, 2004, Orlando.
  • Fogelfeld L, Shaffer T and Lipton R. How Unusual Are Type 2 Patients with Onset before Age 30? American Diabetes Association, 64th Annual Meeting, 2004, Orlando.
  • Shaffer T, Fogelfeld L, Cooper A and Lipton R. Risk factors for complications in uninsured younger-versus older-onset adults wit diabetes. American Diabetes Association, 64th Annual Meeting, 2004, Orlando
  • Kazlauskaite R, Evans A, Mazzone T, Fogelfeld L.Low HDL-cholesterol is associated with ketosis in Hispanic/Latino but not African Americans patients with type 2 diabetes. American Diabetes Association, 64th Annual Meeting, 2004, Orlando